C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.120
+0.070 (3.41%)
At close: Aug 1, 2025, 4:00 PM
2.140
+0.020 (0.94%)
Pre-market: Aug 4, 2025, 7:00 AM EDT
bluebird bio Market Cap
C4 Therapeutics has a market cap or net worth of $150.54 million as of August 4, 2025. Its market cap has decreased by -68.11% in one year.
Market Cap
150.54M
Enterprise Value
-19.80M
1-Year Change
-68.11%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $150.54M, a decrease of -80.52%. That is a compound annual growth rate of -28.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 150.54M | -40.76% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
| Oct 2, 2020 | 772.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |